Scarica l'app Stockscreener
0.1702
4.42%
0.0072
Dopo l'orario di chiusura:
.17
-0.0002
-0.12%
Kala Bio Inc Borsa (KALA) Ultime notizie
Kala Pharmaceuticals Inc (27F0.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
KALA Bio launches on-premises AI platform for biotech sector - Investing.com
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
KALA SEC FilingsKala Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
KALA BIO, Inc. (KALA) stock price, news, quote and history - Yahoo Finance UK
Kala Bio engages advisor to review clinical assets, AI analytics By Investing.com - ca.investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Kala Bio engages advisor to review clinical assets, AI analytics - Investing.com
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities - manilatimes.net
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and ... - Caledonian Record
Kala Bio brings in AI-focused adviser to reassess Phase 2 data - Stock Titan
Kala Bio Delays 2025 Annual Report Filing - tipranks.com
Kala Bio (NASDAQ: KALA) notifies SEC of late 2025 10‑K, cites turnover - Stock Titan
Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA) - Barchart
Bionic Intelligence Research Agent Now Commercially Live - openPR.com
User - The Chronicle-Journal
Kala Bio deploys AI research agent for biotech clients By Investing.com - Investing.com South Africa
Kala Bio Announces Initial Commercial Deployment of Bionic Intelligence Research Agent - MarketScreener
Exclusive: Penny stock Kala Bio transitions to revenue model with AI platform launch - MSN
Kala Bio deploys AI research agent for biotech clients - in.investing.com
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live - The Manila Times
Kala says its private AI research agent is now live for biotech clients - Stock Titan
EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform LaunchKala Bio (NASDAQ:K - Benzinga
KALA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
KALA BIO Inc expected to post a loss of $1.44 a shareEarnings Preview - TradingView
KALA BIO, Inc. (NASDAQ:KALA) Receives Consensus Rating of "Hold" from Analysts - marketbeat.com
Trading Action: Will KALA BIO Inc stock benefit from M A2026 Selloffs & Daily Entry Point Trade Alerts - baoquankhu1.vn
KALA BIO, Inc. (NASDAQ:KALA) Short Interest Up 600.0% in March - MarketBeat
Kala Bio rises on plans to leverage AI - MSN
If You Invested $1,000 in Kala Pharmaceuticals Inc (KALA) - Stock Titan
$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com
FinancialContent$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA) - FinancialContent
KALA BIO (KALA) Projected to Post Quarterly Earnings on Thursday - marketbeat.com
KALA Engages AI Technology for Advancing Psilocybin Drug Development - GuruFocus
Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - Investing News Network
Red Light Holland Deploys Kala Bio AI Platform to Advance Psilocybin Drug PEX010 - tipranks.com
Red Light Holland Engages Kala Bio’s Researgency.AI - GlobeNewswire
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate - TMX Newsfile
AI to speed testing of psilocybin drug PEX010 for addiction and depression - Stock Titan
[144] KALA BIO, Inc. SEC Filing - Stock Titan
Stock Trend Capital Highlights Younet AI’s Exclusive Biotech Partnership with KALA BIO - TipRanks
KALA BIO to launch first commercial AI agent in two weeks - Investing.com Nigeria
KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update - MarketBeat
Why Did KALA Stock Surge 25% Today? - Stocktwits
Form 144 KALA BIO For: 12 March By Investing.com - Investing.com Australia
Kala Bio chases 'Palantir for biotech' dream with new AI platform - MSN
Movement Recap: Does Dragonfly Energy Holdings Corp Equity Warrant have consistent dividend growthQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Morgan Stanley Smith Barney files Form 144 to sell restricted KALA shares (KALA) - Stock Titan
Form 144: Restricted stock sale notice — Kala Pharmaceuticals (NASDAQ: KALA) - Stock Titan
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
After Hours 11 Mar 2026: KALA BIO (KALA NASDAQ) up 24.16% to $0.36, model sees upside - Meyka
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - The Globe and Mail
KALA BIO (KALA) Stock Jumps 70% After Pivoting to AI With ‘Palantir for Biotech’ Vision - MEXC
KALA BIO's 70% Surge: Flow Analysis of the AI Pivot - Bitget
Kala Bio Announces Launch Of First Commercial AI Product - marketscreener.com
KALA BIO (KALA) Stock Soars 70% on AI Agent Launch and ‘Palantir for Biotech’ Strategy - Blockonomi
Why Did KALA Stock Surge 70% In Pre-Market Today? - Asianet Newsable
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):